OBJECTIVE. The purpose of our study was to assess the predictors of early mortality after the creation of transjugular intrahepatic portosystemic shunts (TIPS) for acute variceal bleeding in patients with viral liver cirrhosis.MATERIALS AND METHODS. Seventy-three patients (56 men and 17 women; mean age, 51.3 years) with viral liver cirrhosis who underwent TIPS placement for acute variceal bleeding were studied. Multiple covariates, including demographic, clinical, and biochemical parameters, were included in univariate and multivariate analyses to determine their association with early (30-day) mortality.RESULTS. During the follow-up period (mean, 35 months 3 days), shunt dysfunction occurred in 33 patients (45.2%). Forty-three patients (58.9%) died, and 23 patients (31.5%) died within 30 days of TIPS. Early death was predicted independently by hyperbilirubinemia (> 3 mg/dL; p = 0.004; odds ratio, 10.6) and elevated serum creatinine level (> 1.7 mg/dL; p = 0.018; odds ratio, 12.0).CONCLUSION. Hyperbilirubinemia and elevated serum creatinine level are predictive of early mortality after TIPS creation for acute variceal bleeding in patients with viral liver cirrhosis.he transjugular intrahepatic portosystemic shunt (TIPS) is a well-established therapy for patients with liver cirrhosis complicated by acute or recurrent variceal bleeding that is refractory to endoscopic therapy and intractable ascites [1][2][3][4]. However, TIPS are associated with high early mortality; the 30-day mortality rate ranges from 25% to 30% [1][2][3][4]. Many authors have investigated prognostic factors accurately predicting survival after TIPS placement [5][6][7][8][9][10][11][12][13]. Several factors predictive of poor survival have been recognized: hyponatremia, hyperbilirubinemia, elevated serum alanine aminotransferase, advanced liver disease, emergent TIPS placement, and coexisting renal insufficiency [5][6][7][8][9][10][11][12][13].To date, most studies about TIPS have been from Western countries, and most patients included in these studies had alcoholic liver cirrhosis [1][2][3][4][5][6][7][8][9][10][11][12][13]. However, in Asian countries, hepatitis virus carriers are reported to be 5-20% of the population, and viral hepatitis is the main cause of liver cirrhosis [14,15]. Viral liver cirrhosis is different from alcoholic liver cirrhosis in many aspects such as histologic and morphologic changes, disease progression, treatment options, and incidence of hepatocellular carcinoma (HCC) [16][17][18]. Therefore, it is inappropriate to apply the Western data to patients with viral liver cirrhosis, especially in hepatitis virus-endemic areas. However, a few studies from Asian countries have investigated prognostic factors of TIPS in patients with viral liver cirrhosis. We performed this study to assess the prognostic factors for early mortality after TIPS placement for acute variceal bleeding in patients with viral liver cirrhosis. To our knowledge, this is the first English-language article from a hepatitis virus-endemic area that desc...